Skip to content

Admission of Adult-onset Still Disease Patients in the ICU

Admission of Adult-onset Still Disease Patients in the ICU: a French Retrospective Multicentric Study

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03276650
Acronym
Still-ICU
Enrollment
45
Registered
2017-09-08
Start date
2017-09-01
Completion date
2018-08-01
Last updated
2018-09-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Adult-Onset Still Disease, Critically Ill

Brief summary

Since its first description in 1971, diagnosing adult-onset Still's disease (AOSD), a rare multisystemic disorder considered as a multigenic autoinflammatory syndrome, remains challenging. Rarely, AOSD may present severe systemic manifestations and require intensive care. The main purpose of the Stil ICU study is to make the first description of the epidemiology of critically ill AOSD patients. The investigators will use a retrospective cohort study design with dual recruitment strategies: (1) via the AOSD referral centres network and (2) via a French academic medical ICU network.

Interventions

OTHERdata collection

biological, administrative, clinical, outcome date

Sponsors

Central Hospital, Nancy, France
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* AOSD (history of newly diagnosed) * ICU admission between January 2001 and June 2017

Exclusion criteria

* adults under protection * admission in step-down unit

Design outcomes

Primary

MeasureTime frameDescription
number of patientsAt inclusionNumber of patients fulfilling the inclusion criteria

Secondary

MeasureTime frameDescription
APACHE II24hour after ICU admissionAcute Physiologic Assessment and Chronic Health Evaluation II
Mortalitythrough study completion, maximum 17,5 years after admissionKaplan Meier
Number of rehospitalisation in ICUthrough study completion, maximum 17,5 years after admissionneed for critical care after the first hospitalisation in ICU
number of hospitalisation in internal medicine wardthrough study completion, maximum 17,5 years after admissionnumber of hospitalisation in internal medicine ward after the first ICU stay
recurrent relapsesthrough study completion, maximum 17,5 years after admissionnumber of recurrent flares after the first hospitalisation in ICU

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026